Alaunos Reports Preclinical ALN1003 Liver-Weight Signal After Body-Fat Adjustment
Alaunos reports ALN1003-treated mice showed lower liver weight after adjustment for body fat percentage in a 48-day DIO study.Key Highlights:Original SEC Filing: Alaunos Therapeutics, Inc. [ TCRT ] - 8-K - Jun. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying i…